A new study led by Swansea University has revealed a new way to potentially treat certain autoimmune diseases by targeting a ...

From this core mechanism Fc engineering has evolved over time into the "engine" of therapeutic antibody development. It ...

CERo Therapeutics (CERO) will be presenting data on its lead compound CER-1236 at the Society for Immunotherapy of Cancer conference being held ...

New data provide key mechanistic insights into how TG4050 induces and sustains potent, CD8+ T cell responses in operable HNSCC[*] patients Comprehensive immunogenicity data demonstrate TG4050’s ...

HCB301 is a first-in-class tri-specific immunotherapy targeting SIRPα-CD47, PD-1/PD-L1, and TGFβ; it shows potent macrophage ...

MRT-6160 inhibited disease pathology, including proteinuria, lymphadenopathy, skin lesion formation, autoantibody production, and organomegaly, in a spontaneous autoimmune disease mouse model Data ...

Phase 1a of the trial examined dose escalation of IO-202 as a monotherapy and in combination with azacitidine. Phase 1b of ...

Lewis Zhichang Shi, M.D., Ph.D., professor in the Department of Radiation Oncology, has been named the latest recipient of the school’s Featured Discovery award. This recognition celebrates notable ...